AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18417088 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgical exploration in group 2
Number of subjects: 33
Study 16154486 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg once daily for 8 weeks
Number of subjects: 104
Study 16154486 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg once daily for 8 weeks
Number of subjects: 104
Study 12195096 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal Fluency Test with SPECT activation study in depressed suicidal patients
Number of subjects: 40
Study 12195096 — intervention group
Group type: COMPARATOR
Intervention: Verbal Fluency Test with SPECT activation study in healthy volunteers
Number of subjects: 40
Study 9527402 — intervention group
Group type: EXPERIMENTAL
Intervention: Biocompatible membrane (BCM)
Number of subjects: 153
Study 9527402 — intervention group
Group type: COMPARATOR
Intervention: Bioincompatible membrane (BICM)
Number of subjects: 153
Study 7887549 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 63
Study 7887549 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma infusion
Number of subjects: 63
Study 7887549 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange or plasma infusion
Number of subjects: 63
Study 2576203 — intervention group
Group type: COMPARATOR
Intervention: Transdermal mepindolol (BIO TSD)
Number of subjects: 12
Study 58197 — intervention group
Group type: EXPERIMENTAL
Intervention: 3000 units of vitamin D2 in a capsule weekly
Number of subjects: 0
Study 58197 — intervention group
Group type: EXPERIMENTAL
Intervention: Chupatty flour fortified with vitamin D (6000 units per kg)
Number of subjects: 0
Study 58197 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 31059177 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone (200 mg twice daily)
Number of subjects: 216
Study 31059177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 28101592 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine, mitoxantrone and cyclophosphamide (FCM regimen)
Number of subjects: 120
Study 25901376 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (75%-80% VO2peak, 65%-80% 1RM)
Number of subjects: 159
Study 25901376 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (60%-65% VO2peak, 50%-65% 1RM)
Number of subjects: 159
Study 25901376 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual routines)
Number of subjects: 159
Study 22309243 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-enriched mixture (CEM) cement
Number of subjects: 51
Study 22309243 — intervention group
Group type: COMPARATOR
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 51
Study 21608215 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Qiangdu Recipe (BSQDR), one dose daily, taken in two portions (morning and evening) for six months.
Number of subjects: 360
Study 21608215 — intervention group
Group type: COMPARATOR
Intervention: SIDSM and sulfasalazine, for six months.
Number of subjects: 360
Study 19648605 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 2112
Study 19648605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2112
Study 17082466 — intervention group
Group type: EXPERIMENTAL
Intervention: Seizure free (SF) group, treated with 0 to 3 antiepileptic drugs (AEDs)
Number of subjects: 77
Study 17082466 — intervention group
Group type: EXPERIMENTAL
Intervention: Not seizure free (NSF) group, treated with 1 to 10 AEDs
Number of subjects: 77
Study 17082466 — intervention group
Group type: EXPERIMENTAL
Intervention: NSF patients experiencing nonterminal seizure remissions
Number of subjects: 77
Study 17082466 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of lesions on MRI
Number of subjects: 77
Study 17082466 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal slowing on EEG
Number of subjects: 77
Study 10393137 — intervention group
Group type: EXPERIMENTAL
Intervention: High calcium diet (1180 +/‐ 117 mg)
Number of subjects: 11
Study 10393137 — intervention group
Group type: COMPARATOR
Intervention: Low calcium diet (502 +/‐ 99 mg)
Number of subjects: 11
Study 8894059 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG biofeedback pretraining while listening to infant crying
Number of subjects: 15
Study 8894059 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG biofeedback pretraining without stress
Number of subjects: 15
Study 8894059 — intervention group
Group type: COMPARATOR
Intervention: No stress management pretraining while listening to crying
Number of subjects: 15
Study 2071884 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam capsule (20 mg)
Number of subjects: 60
Study 2071884 — intervention group
Group type: COMPARATOR
Intervention: Temazepam elixir (20 mg)
Number of subjects: 60
Study 6846703 — intervention group
Group type: EXPERIMENTAL
Intervention: Choledochoduodenostomy after choledochotomy (Group A)
Number of subjects: 90
Study 6846703 — intervention group
Group type: COMPARATOR
Intervention: T-tube drainage (Group B)
Number of subjects: 90
Study 31062029 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep duration (each additional hour/day)
Number of subjects: 395803
Study 31062029 — intervention group
Group type: EXPERIMENTAL
Intervention: Short and long sleep duration
Number of subjects: 395803
Study 29683824 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiberoptic nasal intubation
Number of subjects: 70
Study 29683824 — intervention group
Group type: COMPARATOR
Intervention: Blind insertion/direct laryngoscopy
Number of subjects: 70
Study 26399611 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular control (NMC) exercise training programme
Number of subjects: 1564
Study 26399611 — intervention group
Group type: COMPARATOR
Intervention: Standard-practice exercise training programme
Number of subjects: 1564
Study 24470706 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 38
Study 24470706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 23041990 — intervention group
Group type: COMPARATOR
Intervention: Decalcified freeze-dried bone allograft alone (control group)
Number of subjects: 12
Study 23041990 — intervention group
Group type: EXPERIMENTAL
Intervention: Decalcified freeze-dried bone allograft in combination with polylactic acid, polyglycolic acid barrier membrane (test group)
Number of subjects: 12
Study 19855255 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection
Number of subjects: 12
Study 19855255 — intervention group
Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 12
Study 19855255 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Botulinum toxin and Saline)
Number of subjects: 12
Study 18027674 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic method combined with prunrllae oral solution (group B1)
Number of subjects: 56
Study 18027674 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic method (group A1)
Number of subjects: 56
Study 18027674 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 normal thyroidea)
Number of subjects: 56
Study 16153509 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler echocardiographic evaluation of pulmonary regurgitation
Number of subjects: 100
Study 12124949 — intervention group
Group type: EXPERIMENTAL
Intervention: IntraCoil stent treatment
Number of subjects: 93
Study 10202054 — intervention group
Group type: EXPERIMENTAL
Intervention: Banding ligation
Number of subjects: 79
Study 10202054 — intervention group
Group type: COMPARATOR
Intervention: Sclerotherapy
Number of subjects: 79
Study 10202054 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study 7486100 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg i.v. bolus followed by continuous infusion of 5 mg/h for 24 h
Number of subjects: 0
Study 7486100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2278324 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125%
Number of subjects: 90
Study 2278324 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 0.25% plain
Number of subjects: 90
Study 2278324 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125% with adrenaline 1.25 micrograms/ml
Number of subjects: 90
Study 2278324 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.25% with adrenaline 2.5 micrograms/ml
Number of subjects: 90
Study 2278324 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125% with adrenaline 1.25 micrograms/ml and fentanyl 50 micrograms
Number of subjects: 90
Study 30676140 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid prepackaged diet (Ldiet)
Number of subjects: 30
Study 30676140 — intervention group
Group type: COMPARATOR
Intervention: Solid prepackaged diet (Sdiet)
Number of subjects: 30
Study 29779983 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic detailing (AD)
Number of subjects: 64
Study 29779983 — intervention group
Group type: COMPARATOR
Intervention: Mailed quitline materials (MM)
Number of subjects: 64
Study 29779983 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall percentage of quitline registrants hearing about the quitline from any pharmacy
Number of subjects: 64
Study 29779983 — intervention group
Group type: EXPERIMENTAL
Intervention: Quitline cards and brochures distributed
Number of subjects: 64
Study 27312989 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescribed exercise group (E): two 10-min walking sessions every second day at an intensity below self-selected speed
Number of subjects: 59
Study 27312989 — intervention group
Group type: COMPARATOR
Intervention: Control group (C): usual care
Number of subjects: 59
Study 24705442 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic decision support tool
Number of subjects: 111
Study 24705442 — intervention group
Group type: COMPARATOR
Intervention: Memory alone
Number of subjects: 111
Study 22257557 — intervention group
Group type: EXPERIMENTAL
Intervention: Employability interventions (specific interventions not detailed in the abstract)
Number of subjects: 142
Study 22257557 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 142
Study 21236746 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive Watson-Jones approach
Number of subjects: 141
Study 21236746 — intervention group
Group type: COMPARATOR
Intervention: Anterolateral approach with anterior hemimyotomy
Number of subjects: 141
Study 17532826 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU single dose)
Number of subjects: 24
Study 17532826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 16095547 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture care (average of 8 treatments)
Number of subjects: 239
Study 16095547 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture care
Number of subjects: 239
Study 16095547 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 239
Study 12240794 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 mg CONCERTA (methylphenidate HCI) after a high-fat breakfast
Number of subjects: 0
Study 12240794 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ADDERALL XR (mixed amphetamine salts) after a high-fat breakfast
Number of subjects: 0
Study 12240794 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 mg CONCERTA (methylphenidate HCI) after an overnight fast
Number of subjects: 0
Study 12240794 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ADDERALL XR (mixed amphetamine salts) after an overnight fast
Number of subjects: 0
Study 11329107 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE therapy
Number of subjects: 97
Study 8673477 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN‐gamma therapy (recombinant human interferon gamma 1b), administered three times weekly for 12 months
Number of subjects: 30
Study 8673477 — intervention group
Group type: COMPARATOR
Intervention: Placebo (from previous study)
Number of subjects: 30
Study 8673477 — intervention group
Group type: COMPARATOR
Intervention: rIFN‐gamma (from previous study)
Number of subjects: 30
Study 8673477 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN‐gamma therapy
Number of subjects: 30
Study 2313043 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomechanics platform measures of sway
Number of subjects: 43
Study 2313043 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotaped measures of gait
Number of subjects: 43
Study 762470 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning disabled label applied to girls
Number of subjects: 8
Study 762470 — intervention group
Group type: COMPARATOR
Intervention: Normal label applied to girls
Number of subjects: 8
Study 762470 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning disabled label applied to boys
Number of subjects: 8
Study 762470 — intervention group
Group type: COMPARATOR
Intervention: Normal label applied to boys
Number of subjects: 8
Study 31689748 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Education and Rehabilitation Program (PERP)
Number of subjects: 130
Study 31689748 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130
Study 28749175 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthesia to subcutaneous fat level; lidocaine 1‐2 ml
Number of subjects: 157
Study 28749175 — intervention group
Group type: COMPARATOR
Intervention: No local anaesthetic
Number of subjects: 157
Study 28749175 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthesia to deltoid muscle level; 3‐5 ml
Number of subjects: 157
Study 28749175 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthesia to subscapularis muscle level; 6‐8 ml
Number of subjects: 157
Study 24949910 — intervention group
Group type: EXPERIMENTAL
Intervention: Kurasper F
Number of subjects: 30
Study 24949910 — intervention group
Group type: EXPERIMENTAL
Intervention: GrenGloo
Number of subjects: 30
Study 24949910 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond XT
Number of subjects: 30
Study 23797608 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 120
Study 23797608 — intervention group
Group type: COMPARATOR
Intervention: Medication
Number of subjects: 120
Study 23797608 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy
Number of subjects: 120
Study 21889081 — intervention group
Group type: EXPERIMENTAL
Intervention: Haas-type expander
Number of subjects: 33
Study 21889081 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyrax-type expander
Number of subjects: 33
Study 19184084 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximal arm abduction contractions at various angles (15°, 30°, 45°, 60°, 75°, 90°)
Number of subjects: 12
Study 19184084 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximal arm abduction contractions at 45°, 60°, 75°, and 90°
Number of subjects: 12
Study 19184084 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximal arm abduction contractions at 15°
Number of subjects: 12
Study 19184084 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximal arm abduction contractions at 30° to 90°
Number of subjects: 12
Study 17514432 — intervention group
Group type: EXPERIMENTAL
Intervention: WMHM20 (uncooked physically modified cornstarch)
Number of subjects: 21
Study 17514432 — intervention group
Group type: COMPARATOR
Intervention: Uncooked cornstarch
Number of subjects: 21
Study 12954595 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide (5 pmol.kg‐1.min‐1) for 120 min
Number of subjects: 10
Study 12954595 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide infusion
Number of subjects: 10
Study 12954595 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study 11449079 — intervention group
Group type: EXPERIMENTAL
Intervention: Esterified estrogens combined with methyltestosterone (Estratest)
Number of subjects: 19
Study 11449079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 9683204 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times a day
Number of subjects: 743
Study 9683204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 743
Study 9683204 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat continued in year 2
Number of subjects: 743
Study 9683204 — intervention group
Group type: COMPARATOR
Intervention: Placebo switched to Orlistat in year 2
Number of subjects: 743
Study 9683204 — intervention group
Group type: COMPARATOR
Intervention: Placebo continued in year 2
Number of subjects: 743
Study 9683204 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 743
Study 7810176 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan supplemented diet (standard diet + 1.5 g tryptophan)
Number of subjects: 0
Study 7810176 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-rich diet (35% carbohydrate, 40% protein)
Number of subjects: 0
Study 7810176 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich diet (80% carbohydrate)
Number of subjects: 0
Study 7810176 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (60% carbohydrate)
Number of subjects: 0
Study 7810176 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals with different nutrient relation
Number of subjects: 0
Study 3046854 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg aspartame
Number of subjects: 22
Study 3046854 — intervention group
Group type: COMPARATOR
Intervention: 135 mg saccharin
Number of subjects: 22
Study 3046854 — intervention group
Group type: COMPARATOR
Intervention: Unsweetened beverage
Number of subjects: 22
Study 30455167 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention focusing on physical activity (PA) for the first 4 weeks and fruit and vegetable consumption (FVC) for the subsequent 4 weeks.
Number of subjects: 114
Study 30455167 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 114
Study 28224926 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-month worksite-based lifestyle program including personalized lifestyle counseling, physical activity tracker, and sit-stand workstation
Number of subjects: 850
Study 28224926 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 850
Study 26303558 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinking Healthy Programme intervention
Number of subjects: 584
Study 26303558 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (Control)
Number of subjects: 584
Study 26303558 — intervention group
Group type: COMPARATOR
Intervention: Reference group (no prenatal depression)
Number of subjects: 584
Study 23129048 — intervention group
Group type: EXPERIMENTAL
Intervention: JTK-853 (800, 1,200, or 1,600 mg twice daily or 1,200 mg three times daily)
Number of subjects: 24
Study 23129048 — intervention group
Group type: EXPERIMENTAL
Intervention: JTK-853
Number of subjects: 24
Study 21496753 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined student-parent intervention
Number of subjects: 3490
Study 21496753 — intervention group
Group type: COMPARATOR
Intervention: Parent intervention
Number of subjects: 3490
Study 21496753 — intervention group
Group type: COMPARATOR
Intervention: Student intervention
Number of subjects: 3490
Study 21496753 — intervention group
Group type: COMPARATOR
Intervention: Regular curriculum (control condition)
Number of subjects: 3490
Study 18929284 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (bolus dose of 1 microg kg(‐1) and maintenance of 0.7 microg kg(‐1) hour(‐1))
Number of subjects: 80
Study 18929284 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Group TD)
Number of subjects: 80
Study 18929284 — intervention group
Group type: COMPARATOR
Intervention: Saline (control for Group S)
Number of subjects: 80
Study 18929284 — intervention group
Group type: COMPARATOR
Intervention: Saline (control for Group T)
Number of subjects: 80
Study 16470820 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol 160 mg
Number of subjects: 10
Study 16470820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15603468 — intervention group
Group type: EXPERIMENTAL
Intervention: donepezil‐plus‐stimulation group (n = 26)
Number of subjects: 54
Study 15603468 — intervention group
Group type: COMPARATOR
Intervention: donepezil‐only group (n = 28)
Number of subjects: 54
Study 11604980 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (30 minutes)
Number of subjects: 20
Study 11604980 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted rest period (30 minutes)
Number of subjects: 20
Study 10678027 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary curative incision
Number of subjects: 100
Study 10678027 — intervention group
Group type: COMPARATOR
Intervention: Traditional incisional drainage
Number of subjects: 100
Study 8198661 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal betamethasone
Number of subjects: 17
Study 8198661 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal dexamethasone
Number of subjects: 17
Study 8198661 — intervention group
Group type: EXPERIMENTAL
Intervention: Both prenatal betamethasone and postnatal dexamethasone
Number of subjects: 17
Study 8198661 — intervention group
Group type: COMPARATOR
Intervention: No corticosteroid treatment
Number of subjects: 17
Study 8198661 — intervention group
Group type: COMPARATOR
Intervention: Adults (control group)
Number of subjects: 17
Study 8198661 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonates overall
Number of subjects: 17
Study 3446157 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructosamine screening
Number of subjects: 256
Study 3446157 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose screening
Number of subjects: 256
Study 3446157 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose tolerance tests
Number of subjects: 256
Study 30219369 — intervention group
Group type: EXPERIMENTAL
Intervention: LeishTec® vaccine (recombinant Leishmania A2 protein, saponin-adjuvanted)
Number of subjects: 0
Study 30219369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27626285 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician ratings
Number of subjects: 1460
Study 27626285 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient ratings
Number of subjects: 1460
Study 27626285 — intervention group
Group type: EXPERIMENTAL
Intervention: Change score definition
Number of subjects: 1460